摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6,7-二氢吡咯并[2,3-c]氮杂卓-4,8(1H,5H)-二酮 | 72908-87-3

中文名称
6,7-二氢吡咯并[2,3-c]氮杂卓-4,8(1H,5H)-二酮
中文别名
6,7-二氢吡咯并[2,3-C]氮杂卓-4,8(1H,5H)-二酮
英文名称
aldisin
英文别名
Aldisine;6,7-dihydropyrrolo<2,3-c>azepine-4,8(1H,5H)-dione;6,7-dihydro-1H,5H-pyrrolo[2,3-c]azepine-4,8-dione;6,7-dihydropyrrolo[2,3-c]azepine-4,8(1H,5H)-dione;3,10-diaza-bicyclo(5.3.0)deca-1(7),8-diene-2,6-dione;1,5,6,7-tetrahydropyrrolo[2,3-c]azepine-4,8-dione
6,7-二氢吡咯并[2,3-c]氮杂卓-4,8(1H,5H)-二酮化学式
CAS
72908-87-3
化学式
C8H8N2O2
mdl
MFCD08166501
分子量
164.164
InChiKey
AAPGLCCSVSGLFH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    286-288℃
  • 沸点:
    555.9±39.0 °C(Predicted)
  • 密度:
    1.352±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.2
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    62
  • 氢给体数:
    2
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933990090
  • 危险性防范说明:
    P261,P280,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H332,H335
  • 储存条件:
    2-8°C

SDS

SDS:92c0a3f07b5f69a2e86880d76e9f1bdf
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3

反应信息

  • 作为反应物:
    描述:
    6,7-二氢吡咯并[2,3-c]氮杂卓-4,8(1H,5H)-二酮盐酸羟胺sodium acetate 作用下, 以 甲醇 为溶剂, 以95%的产率得到(E)-4-(hydroxyimino)-4,5,6,7-tetrahydropyrrolo[2,3-c]azepin-8(1H)-one
    参考文献:
    名称:
    发现 Aldisine 及其衍生物作为新型抗病毒剂、杀幼虫剂和抗植物病原真菌剂
    摘要:
    基于氢键在药物设计中的广泛应用,设计合成了一系列含有肟、肟醚和腙部分的醛化衍生物,并首次评价了它们的抗病毒、杀幼虫和杀真菌活性。生物测定结果表明,这些衍生物中的大多数对烟草花叶病毒 (TMV) 具有活性。腙衍生物12在 500 mg/L时的体内灭活、治疗和保护活性分别为 52 ± 4、49 ± 1 和 52 ± 3%,与市售抗病毒药物宁南霉素 (57 ± 3, 56 ± 2 和 59 ± 1%)在相同剂量下。抗病毒机制研究表明,化合物12可引起20S CP(涂层蛋白)盘融合和解体,从而影响病毒颗粒的组装。分子对接结果表明化合物12与TMV CP之间存在明显的氢键。大多数衍生物对鳞翅目害虫的幼虫具有活性,例如Mythimna separata、Pyrausta nubilalis和Plutella xylostella。一些化合物还表现出对淡色库蚊的杀幼虫活性;其中化合物9和13的杀幼虫活性分别为
    DOI:
    10.1021/acs.jafc.2c04256
  • 作为产物:
    描述:
    参考文献:
    名称:
    膜生丁二酸和膜溴生丁二酸的总合成:2-氨基-4-氧代-2-咪唑啉-5(Z)-二取代的y亚环体系的立体特异性结构
    摘要:
    通过2-氨基-4-氧代-2-咪唑啉-5(Z)-二取代的亚芳基环系统的新型立体有择结构,实现了膜虫碱(1a)和膜溴虫碱(1b)的第一个全合成。
    DOI:
    10.1016/0040-4039(94)02222-w
点击查看最新优质反应信息

文献信息

  • Synthesis of pyrroloazepines. Facile synthesis of 2-substituted pyrrole derivatives by the phosgene method
    作者:Hidetsura Cho、Shinsuke Matsuki、Akira Mizuno、Hirokazu Annoura、Toshio Tatsuoka
    DOI:10.1002/jhet.5570340115
    日期:1997.1
    A highly convenient method for the synthesis of 2-substituted pyrrole derivatives 7a-c from pyrrole using phosgene was developed. Successively, 7-methyl-6,7-dihydro-1H,5H-pyrrolo[2,3-c]azepine-4,8-dione 1a and 6,7-dihydro-1H,5H-pyrrolo[2,3-c]azepine-4,8-dione 1b (aldisin) were synthesized by phosphorus pentoxide/methanesulfonate and polyphosphoric acid cyclization.
    开发了一种使用光气从吡咯合成2-取代的吡咯衍生物7a-c的非常方便的方法。依次为7-甲基-6,7-二氢-1 H,5 H-吡咯并[2,3 - c ]氮杂-4,8-​​二酮1a和6,7-二氢-1 H,5 H-吡咯并[2 ,3- ç ]氮杂卓-4,8-二酮1B(aldisin)通过五氧化二磷/甲磺酸和多磷酸环化合成。
  • Stereoselective synthesis of (Z)-axino- and (Z)-debromoaxinohydantoin
    作者:Federico Tutino、Helena Posteri、Daniela Borghi、Francesca Quartieri、Nicola Mongelli、Gianluca Papeo
    DOI:10.1016/j.tet.2008.12.053
    日期:2009.3
    (Z)-Axinohydantoin and (Z)-debromoaxinohydantoin, two pyrrole–imidazole alkaloids isolated from different marine sponges, possess moderate activities in inhibiting the progress of the cell cycle at different phases. A stereoselective synthesis of both natural products was achieved. The key step in the synthetic pathway was the installation of the hydantoin northern ring by using 1-benzoyl-2-methylsulfanyl-1
    从不同海洋海绵中分离出的两种吡咯-咪唑生物碱(Z)-轴索乙内酰脲和(Z)-地溴代乙内酰脲,在不同阶段抑制细胞周期进程具有适度的活性。实现了两种天然产物的立体选择性合成。合成途径中的关键步骤是通过使用1-苯甲酰基-2-甲基硫烷基-1,5-二氢咪唑-4-酮来安装乙内酰脲北环。
  • Approaches to the Synthesis of 5-Benzylidene-2-imidazolin-4-ones
    作者:RH Prager、C Tsopelas
    DOI:10.1071/ch9900367
    日期:——

    Aromatic aldehydes , but not ketones, can be condensed with glycocyamidine . The corresponding alkylbenzylideneglycocyamidines may be made from glycidic esters by reaction with guanidine, followed by cyclization with acetic anhydride. A number of mono- and di -acetylated derivatives of 6,7-dihydropyrrolo[2,3-c]azepine-4,8(1H,5H)- dione have been prepared, but failed to undergo the Darzens reaction. Bromo- and iodo-2-arylazoimidazoles, protected on nitrogen by the methoxyethoxymethyl group, failed to undergo clean lithiation.

    芳香醛可以与甘氨脒缩合,但酮类不行。相应的烷基亚苄基甘氨脒可通过与胍反应,然后与乙酸酐环化,从缩水甘油酯中制取。已制备出一些 6,7-二氢吡咯并[2,3-c]氮杂卓-4,8(1H,5H)-二酮的单乙酰化和二乙酰化衍生物,但这些衍生物未能发生达尔曾斯反应。 在氮上受甲氧基乙氧基甲基保护的溴代和碘代-2-芳基偶氮咪唑未能进行清洁的石化作用。
  • Synthesis of indolo/pyrroloazepinone-oxindoles as potential cytotoxic, DNA-intercalating and Topo I inhibitors
    作者:Manasa Kadagathur、Arbaz Sujat Shaikh、Biswajit Panda、Joel George、Regur Phanindranath、Dilep Kumar Sigalapalli、Nagesh A. Bhale、Chandraiah Godugu、Narayana Nagesh、Nagula Shankaraiah、Neelima D. Tangellamudi
    DOI:10.1016/j.bioorg.2022.105706
    日期:2022.5
    conjugates was synthesized and evaluated for their antiproliferative activity against a panel of selected human cancer cell lines including A549 (lung cancer), HCT116 (colon cancer), MCF7 (breast cancer), and SK-MEL-28 (melanoma). Among the synthesized molecules (14a-m and 15a-d), compound 14d displayed remarkable activity against A549, HCT116 and SK-MEL-28 cells with IC50 values < 4 μM with the best
    合成了一系列 17 种吲哚/吡咯并氮杂酮-羟吲哚偶联物,并评估了它们对一组选定的人类癌细胞系的抗增殖活性,包括 A549(肺癌)、HCT116(结肠癌)、MCF7(乳腺癌)和 SK-MEL -28(黑色素瘤)。在合成的分子(14a - m和15a - d)中,化合物14d对 A549、HCT116 和 SK-MEL-28 细胞表现出显着的活性,IC 50值 < 4 μM,具有最佳的细胞毒性和对肺癌的 13 倍选择性细胞(IC 50值为 2.33 μM)高于正常大鼠肾细胞(NRK)。此外,14d介导的细胞凋亡以剂量依赖性方式影响癌细胞的细胞和核形态。伤口愈合和克隆形成测定推断细胞生长和迁移的抑制。化合物14d的靶向研究证实了其 DNA 嵌入能力和 Topo I 抑制活性,这已通过分子建模研究得到加强。最后,通过进行计算机ADME/T 预测研究来确定有效化合物的药物相似性。
  • Synthesis and evaluation of novel anti-proliferative pyrroloazepinone and indoloazepinone oximes derived from the marine natural product hymenialdisine
    作者:Alex W. White、Nicholas Carpenter、Jerome R.P. Lottin、Richard A. McClelland、Robert I. Nicholson
    DOI:10.1016/j.ejmech.2012.08.022
    日期:2012.10
    properties. The synthesis and biological evaluation of a novel series of pyrroloazepinone and indoloazepinone oximes is reported. These compounds showed promising growth inhibition activity against four human cancer cell lines but did not significantly inhibit the cell cycle regulator cyclin dependent kinase 2. The most active compounds in this series displayed improved anti-proliferative activity over the
    四氢a庚酮药效基团是许多有趣的化合物的组成部分,包括几种具有抗癌特性的海洋天然产物。报道了一系列新的吡咯并ze庚酮和吲哚并ze庚酮肟的合成和生物学评价。这些化合物对四种人类癌细胞系显示出有希望的生长抑制活性,但并未显着抑制细胞周期调节剂细胞周期蛋白依赖性激酶2。该系列中最具活性的化合物显示出比相关的合成吲哚并西平kenpaullone更高的抗增殖活性。氮杂环庚烷药效团显示的结构活性关系表明了用于抗癌药物发现的几种新的先导化合物。
查看更多

同类化合物

环戊二烯并[4,5]氮杂卓并[2,1,7-cd]吡咯里嗪 吡咯并[1,2-a]氮杂-5-酮 六氢-1H-吡咯并[1,2-A]氮杂卓-5(6H)-酮 N,N-二甲基-3-(3-甲基-1,2,4,5-四氢氮杂卓并[4,5-b]吲哚-6-基)丙-1-胺 9-氟-1,2,3,4,5,6-六氢氮杂卓并[4,5-b]吲哚 7,8-二氢-5H-吡咯并[1,2-A]氮杂环庚烷-9(6H)-酮 6-叔-丁基3A-乙基八氢吡咯并[2,3-D]氮杂卓-3A,6(2H)-二甲酸基酯 6,7-二氢吡咯并[2,3-c]氮杂卓-4,8(1H,5H)-二酮 5H-吡咯并[1,2-a]氮杂卓-7-醇 5,9:7,11-二亚甲基-5H-吡咯并[1,2-a]吖壬英-3-羧酸,6,7,8,9,10,11-六氢-,甲基酯 4-(2-氨基-1H-咪唑-5-基)-2,3-二溴-6,7-二氢吡咯并[2,3-c]氮杂卓-8(1H)-酮 4-(2-氨基-1H-咪唑-4-基)-2,3-二溴-4,5,6,7-四氢吡咯并[2,3-c]氮杂卓-8(1H)-酮 4-(2-氨基-1,5-二氢-5-氧代-4H-咪唑-4-亚基)-4,5,6,7-四氢-吡咯并[2,3-c]氮杂卓-8(1H)-酮 3-苄基-1,2,3,4,5,6-六氢氮杂卓并[4,5-b]吲哚 3-(3,9-二甲基-1,2,4,5-四氢氮杂卓并[4,5-b]吲哚-6-基)-N,N-二甲基丙烷-1-胺 2H,3H-氧杂环丁烷并[3,2-d]吡咯并[1,2-a]氮杂卓 2-溴-6,7-二氢-1h,5h-吡咯并[2,3-c]氮杂烷-4,8-二酮 2,5-已炔二醇 2,3,4,5-四氢-N,N-二甲基-2-(3,4,5-三甲氧基苯甲酰基)-氮杂卓并(3,4-b)吲哚-10(1H)-丙胺 11-氧杂-3,10-二氮杂三环[7.2.1.03,7]十二碳-1,4,6,9-四烯 1,4,5,6,7,8-六氢吡咯并[3,2-b]氮杂卓 1,2,3,4,5,6-六氢氮杂环庚烷[4,3-B]吲哚盐酸盐 1,2,3,4,5,6-六氢-9-甲基氮杂卓并[4,5-b]吲哚 1,2,3,4,5,6-六氢-6-甲基氮杂革[4,5-b]吲哚盐酸盐 1,2,3,4,5,6-六氢-3-甲基氮杂卓并[4,5-b]吲哚 (1R*,2E,11S*)-2-(cyclohexylmethylene)-1-(phenylsilyl)methyloctahydropyrrolo[1,2-a]azepine (R)-2-(6,7,8,9-tetrahydro-5H-pyrrolo[1,2-a]azepin-9-yl)-acetaldehyde curvulamine (3aR,8aS)-tert-butyl octahydropyrrolo[3,4-d]azepine-2(1H)-carboxylate hydrochloride tert-butyl 6-(2-amino-2-oxoethyl)-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate 3-benzoyl-10-bromo-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 3-(tert-butyloxycarbonyl)-10-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 1,2,3,4,5,6-hexahydro-3-dimethylaminoethyl-5-hydroxymethylazepino[4,5-b]indole 1,2,3,4,5,6-hexahydro-3-dimethylaminoethyl-5-hydroxymethyl-6-methylazepino[4,5-b]indole (Z)-2,3,9,9a-tetrahydro-6,6-dimethyl-9-methylene-8-vinyl-1H-pyrrolo[1,2-a]azepin-5(6H)-one 2,3,4,5,6,7-hexahydro-1H-3a,8,13,13b-tetraazabenzo[b]cyclopenta[1,2,3-jk]fluorene 2,3,4,5,6,7-hexahydro-1H-3a,8,11,11b-tetraazacyclohepta[1,2,3-jk]fluorene 1-Benzyloxy-2-methoxy-7,8,9,10-tetrahydro-6H-azepino<1,2-a>indole-11-carbaldehyde 3-benzoyl-10-(2-propoxyphenyl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 2-phenyl-2,4,5,6-tetrahydro-1H-6-azabenzo[a]cyclohepta[cd]azulen-1-one 2-carbetoxy-3-(N,N-dimethyl)aminomethyleneamino-8-oxo-8H-4,5,6,7-tetrahydropyrrolo<2,3-c>azepine 3-benzoyl-10-[2-(trifluoromethyl)phenyl]-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 3-benzoyl-10-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 6-[2-(4-fluorophenyl)ethyl]-3,4,5,6-tetrahydroazepino[4,3-b]indol-1(2H)-one 5-(2-hydroxy-3-morpholin-4-yl-propyl)-3-methyl-4-oxo-1,4,5,6,7,8-hexahydro-pyrrolo[3,2-c]azepine-2-carbaldehyde 6-(2-phenylethyl)-3,4,5,6-tetrahydroazepino[4,3-b]indol-1(2H)-one 11-(tert-butyldimethylsilyloxy)-1-trimethylsilyl-3a,4,11,12-tetrahydro-3H-cyclopenta[5,6]azepine[1,2-a]indole-2-one tert-butyl 8,9-dichloro-6-[2-(2,3-dimethylanilino)-2-oxoethyl]-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate tert-butyl 9,10-dichloro-6-[2-(2,3-dimethylanilino)-2-oxoethyl]-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate tert-butyl (1R,4S)-1-(benzylcarbamoyl)-3-oxo-2-((S)-1-phenylethyl)-1,2,3,4,5,10-hexahydroazepino[3,4-b]indol-4-ylcarbamate